ArticleBone marrow transplantation2021

Post-transplant cyclophosphamide demonstrates lower non-relapse mortality and better graft-versus-host disease/relapse-free survival compared with antithymocyte globulin in unrelated donor hematopoietic stem cell transplantation. A single-center experience.

M Berro et al.PubMed ↗Publisher ↗

No numbers read from the abstract.